v3.26.1
BALANCE SHEET ACCOUNT DETAILS - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Balance Sheet Related Disclosures [Abstract]    
Compensation $ 3,085 $ 3,475
Drug product manufacturing subcontractor 307 292
Commercial, marketing and sales 218 818
Insurance 0 265
Accrued interest 0 234
Milestones and royalties payable 14,334 7,819
Accrued gross-to-net adjustments 2,364 1,778
Other 437 683
Total accrued expenses $ 20,745 $ 15,364